{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:19:13Z","timestamp":1779347953859,"version":"3.51.4"},"reference-count":46,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            A population-based cohort study was conducted in the Dutch PHARMO database to investigate prevalence and patterns of anti-infective medication use in children and adolescents with type 1 diabetes (T1D) before and after the onset of this disease. All patients &lt;19 years with at least 2 insulin prescriptions (1999 to 2009) were identified (T1D cohort) and compared with an age- and sex-matched (ratio: 1 up to 4) diabetes-free reference group. The prevalence and average number of anti-infective use was studied from (up to) 8 years before until a maximum of 4 years after the onset of T1D. A total of 925 patients with T1D and 3,591 children and adolescents in the reference cohort (51% boys, mean age of 10.1 [standard deviation, 4.5] years) were included. The overall prevalence of anti-infective use (62.6 compared to 52.6%,\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001) and average number of prescriptions (2.71 compared to 1.42 per child,\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001) in the T1D cohort were significantly higher than those in the reference cohort after the onset of diabetes. This pattern was consistent across sex and age categories and already observed in the year before the onset of type 1 diabetes. Patients in the T1D cohort received more antibacterials (49.8 compared to 40%,\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001), antimycotics (4.0 compared to 1.3%,\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001), antivirals (2.5 compared to 0.4%,\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.001), and second-line antibiotics, such as aminoglycosides, quinolones, and third-generation cephalosporins and carbapenems. Our findings that elevated anti-infective use in the T1D cohort exists in the period before the onset of type 1 diabetes and the consumption of more second-line anti-infective compounds in this time period warrant further research.\n          <\/jats:p>","DOI":"10.1128\/aac.03080-14","type":"journal-article","created":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T06:12:01Z","timestamp":1401775921000},"page":"4666-4674","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["Population-Based Cohort Study of Anti-Infective Medication Use before and after the Onset of Type 1 Diabetes in Children and Adolescents"],"prefix":"10.1128","volume":"58","author":[{"given":"Soulmaz","family":"Fazeli Farsani","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.","family":"Souverein","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marja M. J.","family":"van der Vorst","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, St. Antonius Hospital, Nieuwegein, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherijne A. J.","family":"Knibbe","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, Utrecht, the Netherlands"},{"name":"Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthonius","family":"de Boer","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aukje K.","family":"Mantel-Teeuwisse","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.04.008"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.12.3353"},{"key":"e_1_3_2_4_2","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2013","unstructured":"International Diabetes Federation. 2013. IDF diabetes atlas, 6th ed. International Diabetes Federation, Brussels, Belgium.","edition":"6"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.158"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.10340"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.8.695"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2188"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/431587"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.2.510"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1146"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.12.014"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-402"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.04.009"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(95)00552-8"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(97)00040-1"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-1496"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1722"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(00)00255-8"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.94253"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-3068"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-9-31"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg302"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2004.tb02940.x"},{"key":"e_1_3_2_25_2","first-page":"735","article-title":"Age- and sex-specific antibiotic prescribing patterns in general practice in England and Wales in 1996","volume":"49","author":"Majeed A","year":"1999","unstructured":"MajeedAMoserK. 1999. Age- and sex-specific antibiotic prescribing patterns in general practice in England and Wales in 1996. Br. J. Gen. Pract. 49:735\u2013736.","journal-title":"Br. J. Gen. Pract."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.3.451"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000053305"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007690"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-006-9024-y"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp038"},{"key":"e_1_3_2_31_2","first-page":"47","article-title":"Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation","volume":"43","year":"2000","unstructured":". 2000. Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB Substudy 2 Study Group. Diabetologia 43:47\u201353.","journal-title":"EURODIAB Substudy 2 Study Group. Diabetologia"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0078-2"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.277673"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit439"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2012.132"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.12.1961"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp065"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.13.19"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01062-8"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1369-5274(00)00129-6"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01875553"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03347.x"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2345"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-012-0393-2"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12003"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6044"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0906948"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.03080-14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.03080-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:50:48Z","timestamp":1645483848000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.03080-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1128\/AAC.03080-14"],"URL":"https:\/\/doi.org\/10.1128\/aac.03080-14","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"2014-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}